1,357
Participants
Start Date
September 30, 2009
Primary Completion Date
November 30, 2009
Study Completion Date
October 31, 2010
MF59-eH1N1
MF59 adjuvanted with egg-derived A/H1N1 antigen. MF59-eH1N1 vaccine is the same vaccine as A/H1N1-SOIV (Swine Origin A/H1N1 Influenza Virus).
Instituto Nacional de Ciencias, Tlalpan
Pediatric Physicians Research, Inc., Jefferson Hills
Pediatric Alliance - Greentree Division (pediatrics), Pittsburgh
UPMC/Community Medicine (pediatrics), Greenville
Children's Health Care -West, Erie
PI-Coor Clinical Research, Burke
Virginia Commonwealth University, Richmond
Capital Pediatrics and Adolescent Ctr., Raleigh
Pediatrics and Adolescent Medicine, Marietta
Pediatrics and Adolescent Medicine, Woodstock
Holston Medical Group, Kingsport
Bluegrass Clinical Research, Inc (Brownsboro for drug shipment), Louisville
Dr. Senders and Associates, Pediatrics, Cleveland
Prestige Clinical Research, Franklin
Bluegrass Clinical Research, Inc., New Albany
Northern Illinois Research Associates, DeKalb
Heartland Research Associates LLC, Arkansas City
Heartland Research Associates LLC, Newton
Meridien Clinical Research, Omaha
IPS Research, Oklahoma City
Research Across America, Dallas
West Houston Clinical Research Service, Houston
Pediatric Healthcare of NW Houston, Tomball
1st International Research Centers, Thornton
J.Lewis Research, Inc./Foothill Family Clinic, Salt Lake City
J. Lewis Research, Inc./Foothill Family Clinic South, Salt Lake City
Clinical Research Center of Nevada, Henderson
Center for Clincal Trials, LLC, Paramount
Center for Clinical Trials, LLC, Paramount
Center for Clinical Trials of San Gabriel, West Covina
Madera Family Medical Group, Madera
The Portland Clinic LLP, Beaverton
Rockwood Research Center, Spokane
Premier Health Research Center, LLC, Downey
Omega Clinical Research, Warwick
Lead Sponsor
Novartis Vaccines
INDUSTRY